James Novak, MD PhD FACP FASN FNKF

Congratulations to incoming @HFHNephFellow fellows Abdelhadi Farouji, Aqsa Pervez, and Ali Taleb and nephrology/critical care fellow Srinidhi Shyamkumar! @HFHIntMedRes @HenryFordHealth

Congratulations to our 2024 @HFHNephFellow graduates, Drs. @klodiahermez and @AmulyaRajagopal (who sent me a lovely parting gift shown below)!

Our first-year #nephrology fellow Sandeep Kaur presenting at ⁦@nkf⁩ Spring Clinical Meeting! ⁦@HenryFordHealth⁩ ⁦@HFHIntMedRes⁩

@anniebelch @LifeAtPurdue Thanks, I’ll let him know!

@JamesNovakNeph @LifeAtPurdue Happy to chat with him if he would like to get involved in doing research in CKD 😊

My son Josh was admitted to and has enrolled at #Purdue @LifeAtPurdue for Fall 2024. We’re super excited to be a #Boilermaker family! #OnlyPurdue

@anniebelch @LifeAtPurdue Hammer down!

@JamesNovakNeph @LifeAtPurdue Boiler up!

IntraCity Kidney Grand Rounds with ⁦@HFHNephFellow⁩ fellows, left to right, Hazem Albashash, Stefani Thompson, Luis Osorio, and Amulya Rajagopal.

@Nephro_Sparks @nkf I got this today also, whereas my FNKF was awarded about 8 years ago. Why now @nkf?

thanks @nkf

@KatieKwonMD @ASNKidney Some special topic modules are on the way, such as onco-nephrology, from the Continuous Professional Development Committee. #KSAP also fills that role to some extent, although not an organized curriculum, covering the breadth of nephrology with extensive question discussions.

@NephRodby That is hilarious! 😆

Don't ask me why now, but I haven't posted this in a while, and is timeless. Warning, some F bombs youtube.com/watch?v=JsIiGo…

A photogenic and talented group of physicians!

We're pleased to announce that we filled all positions in the #NRMP #Match2024. Introducing next year's fellows: Ryan Goleniak and Muhammad Monk, MDs (nephrology/critical care) and Tseng “Alex” Huang and Jocelynn Rajanayagam (nephrology). Congratulations to all!

@MChanMD @NephJC In direct costs, that’s true, but there are also downstream costs of dialysis: infections, procedures, and hospitalizations. #NephJC

T3g: Sparsentan it doesn’t come free. 30 tablets (200 mg/tb)= 10 434 $ 💰In DUPLEX trial pts were on 400mg/d At least from the part of the globe I am from, 3-6 months of treatment can buy a 🏠 (duplex). Maybe it feels cheaper for the US? #NephJC drugs.com/price-guide/fi…

@rheault_m @NephJC @gokidgo Isn’t there evidence of benefit for steroids in some patients with genetic causes of FSGS (strangely)? #NephJC

@JamesNovakNeph @NephJC @gokidgo Genetic testing is almost more important to tell me what NOT to give to my patients. I wouldn't give steroids to a patient with podocin mutations for example. #NephJC

T0e: @goKIDGO guideline suggests genetic testing when biopsy is positive for FSGS and have lower than nephrotic proteinuria And there are more genes than all-known APOL-1, coding for almost any process in the glomerulus #NephJC nature.com/articles/s4158…

@NephJC @NephroSeeker The epitome of this type of nonspecific effect is proteinuria reduction with ACEI/ARB. Probably indicated for most causes of FSGS, even if just a pattern of injury. #NephJC

T0g: Giving diverse etiology, there are diverse targets when it comes to treatment. Even if they don’t adress the cause, some of them might help. Protecting the podocyte, slowing/ stopping fibrosis, not uncommon when treating every GN or CKD Infographic by @NephroSeeker #nephjc

James Novak @HFHNephFellow TPD, KSAP EIC, NSMC ‘18 #NephJC

Encouraging findings about GLP1 (below), also GIP and glucagon triple therapy (not shown): #KidneyWk

@NephroticSyn @ASNKidney Probably? But there’s a long history of surrogate markers not translating to clinical benefit, so it’d be nice to know for sure.

@JamesNovakNeph @ASNKidney So, based on the rule that leaking protein is bad, the reduction of proteinuria is a positive outcome regardless of no difference in rate filtration? Anything on Sparsentan for FSGS.

Sparsentan also better than irbesartan for proteinuria, and maybe slightly for eGFR decline, in IgAN: ⁦@ASNKidney⁩ #KidneyWeek